Introduction {#sec1}
============

In the recent years, cross-dehydrogenative coupling (CDC) reactions have received substantial interest. The major advancements made through studies in this area^[@ref1]−[@ref10]^ have enabled CDC reactions to become highly attractive processes for formation of a variety of types of bonds. Particularly, interesting is the fact that these oxidative cross-coupling processes can be employed to form C--C bonds between two C--H components in an intermolecular^[@ref11]−[@ref20]^ or intramolecular^[@ref21]−[@ref24]^ manner. Moreover, this approach has been extended to the formation of C--N,^[@ref25]−[@ref29]^ C--O,^[@ref30],[@ref31]^ C--S,^[@ref32],[@ref33]^ S--N,^[@ref34],[@ref35]^ C--P,^[@ref36],[@ref37]^ and S--P^[@ref38]^ bonds. Also, CDC reactions have sustainable and green natures including step and atom economy, and they avoid the need for prefunctionalization of reactants.^[@ref39],[@ref40]^ Among the most significant C--C dehydrogenative cross-coupling reactions are those that bring about bond formation between C(sp^2^)--H and C(sp^3^)--H centers. However, processes of this type require activation of the less-reactive C(sp^3^)--H centers mainly via employment of transition-metal catalysts such as palladium (Pd),^[@ref41]^ copper (Cu),^[@ref42]^ gold (Au),^[@ref43]^ iron (Fe),^[@ref46]^ ruthenium (Ru),^[@ref8],[@ref47]^ iridium (Ir),^[@ref48]^ cobalt (Co),^[@ref49]^ and vanadium (V),^[@ref50]^ or nonmetal catalysts like rose bengal,^[@ref51]^ iodine,^[@ref33],[@ref52]^ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone,^[@ref53]^ eosin,^[@ref54]^ and phenyliodonium diacetate^[@ref55]^ along with suitable oxidants.

In the study described below, which is a continuation of our research efforts focusing on pyrazole and pyridine scaffolds,^[@ref44],[@ref45]^ we developed a metal catalyst-free protocol for the C(sp^2^)--C(sp^3^) dehydrogenative cross-coupling reactions between 1-amino-2-imino-pyridines and 1-aryl-5-pyrazolones that produce (pyrazol-4-ylidene)pyridine derivatives and utilize O~2~ as the sole oxidant. One important benefit of the new process is that the reactants are common, pharmaceutically important scaffolds used in the synthesis of pharmacologically active compounds. Moreover, the pyrazole moiety in the products is a common structural component of substances utilized in many areas.^[@ref56],[@ref57]^ In particular, the pyrazole moiety is present in many organic compounds that serve as antibacterial,^[@ref58]−[@ref63]^ antifungal,^[@ref64],[@ref65]^ anti-inflammatory,^[@ref66],[@ref67]^ antioxidant,^[@ref68]^ anticancer,^[@ref69]−[@ref72]^ antituberculosis,^[@ref73],[@ref74]^ anti-alzheimer,^[@ref75]^ antidiabetic,^[@ref76],[@ref77]^ antiviral,^[@ref78]^ antimalarial,^[@ref79]^ antileishmanial,^[@ref80]^ and antiparkinson^[@ref81]^ agents. Moreover, the pyridine group in the products of the new cross-coupling reactions is a common structural feature of a wide range of pharmaceutically and biologically active substances including anticancer, antitumor,^[@ref82]−[@ref84]^ antiviral,^[@ref85]^ antimicrobial,^[@ref86]^ antidiabetic,^[@ref87]^ antioxidant,^[@ref88]^ anti-inflammatory,^[@ref89]^ and antimalarial^[@ref90]^ agents.

Results and Discussion {#sec2}
======================

Studies aimed at the development of a method for dehydrogenative cross-coupling between the 1-amino-2-imino-pyridine and pyrazolone derivatives commenced by exploring the reaction of 1-amino-2-imino-4-(chlorophenyl)-1,2-dihydropyridine-3-carbonitrile (**3a**) and 3-methyl-1-phenyl-5-pyrazolone (**4a**) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). The method used to prepare **3a** and related 1-amino-2-imino-pyridine derivatives **3b--f** involves a two-step sequence that begins with the preparation of enaminonitriles **2a--f**, through reactions of the corresponding ethylidenemalononitriles **1a--f** with dimethylformamide dimethylacetal (DMF--DMA) ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Enaminonitriles **2a--f** were then transformed to the respective targets **3a--f** via thermally induced reactions with hydrazine hydrate in ethanol (cf. [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). In the initial effort, we observed that heating a mixture of **3a** (3 mmol) and 3-methyl-1-phenyl-5-pyrazolone (**4a**) (3 mmol) in ethanol (10 mL) at reflux under an air atmosphere for 24 and 48 h leads to complete recovery of the starting materials ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). This process failed to produce products even when carried out in the presence of Pd(OAc)~2~ (10 mol %) with air or Cu(OAc)~2~ as oxidants (entries 2,3) and when solvents such as methanol, acetonitrile, propanol, dioxane, toluene, and H~2~O are employed (entries 4--9). In contrast, reactions of **3a** (but not with **4a**) did take place to generate the corresponding triazolo\[1,5-*a*\]pyridine derivatives **5a** and **5b** when *N*,*N*-dimethylformamide (DMF) or acetic acid was used as solvents. Interestingly, when reaction of **3a** with **4a** is conducted in ethanol containing 2 equiv acetic acid under an air atmosphere at 130 °C, the (pyrazol-4-ylidene)pyridine **6a** is produced in a 38% yield (entry 12).

![Preparation of 1-Amino-2-imino-pyridine Derivatives **3a--f**](ao-2019-01650b_0003){#sch1}

###### Optimization of Reaction of 1-Aminopyridine **3a** and Pyrazolone **4a**[a](#t1fn1){ref-type="table-fn"}

  entry    catalyst           solvent       additive (equiv)   oxidant or gas      product (% yield)
  -------- ------------------ ------------- ------------------ ------------------- -------------------
  1                           EtOH                             Air                  
  2        Pd(OAc)~2~         EtOH                             air                  
  3        Pd(OAc)~2~         EtOH                             Cu(OAc)~2~           
  4        \- or Pd(OAc)~2~   MeOH                             air or Cu(OAc)~2~    
  5        \- or Pd(OAc)~2~   CH~3~CN                          air or Cu(OAc)~2~    
  6        \- or Pd(OAc)~2~   propanol                         air or Cu(OAc)~2~    
  7        \- or Pd(OAc)~2~   1,4-dioxane                      air or Cu(OAc)~2~    
  8        \- or Pd(OAc)~2~   toluene                          air or Cu(OAc)~2~    
  9        \- or Pd(OAc)~2~   water                            air or Cu(OAc)~2~    
  10       \- or Pd(OAc)~2~   DMF                              air                 **5a** (72)
  11       - or Pd(OAc)~2~    AcOH                             air                 **5c** (74)
  12                          EtOH          AcOH(2)            air                 **6a** (38)
  13                          EtOH          AcOH(4)            air                 **6a** (61)
  14                          EtOH          AcOH(6)            air                 **6a** (76)
  **15**                      **EtOH**      **AcOH(6)**        **O**~**2**~        **6a** (92)
  16                          EtOH          AcOH(6)            Ar                  **6a** (7)

Reaction conditions: 1-amino-2-imino-pyridine **3a** (3 mmol), pyrazolone **4a** (3 mmol), in solvent (10 mL), catalyst (10 mol % in case of using Pd(OAc)~2~), oxidant air, O~2~ (1 atm) or (2 equiv in case of using Cu(OAc)~2~), and additive, at 130 °C, for 24 h.

The structure of **6a** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}) was assigned using spectral and X-ray crystallographic data. Mass spectrometric analysis showed that **6a** has an exact mass of *m*/*z* 416.1147 and a corresponding atomic composition of C~22~H~17~ClN~6~O. The ^1^H NMR spectrum of this substance in dimethyl sulfoxide (DMSO) contains a singlet at 6.72 ppm (pyridine H-5), two singlets at 7.36 and 8.64 ppm corresponding to the two NH~2~ moieties, and a singlet at 2.28 ppm associated with the methyl group. The ^1^H NMR resonances in the 7.06--8.04 ppm region are associated with the nine aromatic protons in **6a**. Moreover, the ^13^C{^1^H} NMR spectra of **6a** contain the expected 18 signals. Finally, X-ray single-crystallographic analysis of the related (pyrazol-4-ylidene)pyridines **6b** and **6k**, prepared using the same general method (see below and [Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}), enables unambiguous assignment of the structure of this substance. An exploratory study aimed at optimizing the process showed that the quantity of acetic acid has an impact on the efficiency of the process. Specifically, reactions of **3a** with **4a** in EtOH containing 4 or 6 equiv of HOAc under an air atmosphere at 130 °C were found to form **6a** in improved respective yields of 61 and 76% (entries 13,14). Furthermore, when the amount of HOAc exceeds 6 equiv, the process becomes complicated by the formation of increasing quantities of the undesired triazolo\[1,5-*a*\]pyridine derivative **5b**. Additional studies demonstrated that conducting reaction of **3a** with **4a** in EtOH containing 6 equiv of HOAc at 130 °C under an oxygen instead of air atmosphere leads to production of **6a** in a dramatically high 92% yield (entry 15). Finally, reaction under the same conditions, except using a degassed solvent system and an argon rather than oxygen atmosphere, takes place to form **6a** in only 7% yield (entry 16).

![Plot of X-ray crystallographic data for **6b**.](ao-2019-01650b_0001){#fig1}

![Plot of X-ray crystallographic data for **6k**.](ao-2019-01650b_0002){#fig2}

![Reactions of 1-Amino-2-imino-pyridine **3a** with the Pyrazolone **4a**](ao-2019-01650b_0004){#sch2}

Having developed the optimized conditions for the new (pyrazol-4-ylidene)pyridine forming process, we next investigated its substrate scope. For this purpose, we probed reactions of a diverse range of 1-amino-2-imino-pyridines **3a--f**, which are prepared by the sequences shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"} and contain either electron-donating or electron-withdrawing 4-aryl substituents, with several 1,3-disubstituted-pyrazolones **4a--d**. The results ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) show that the nature of substituents on the aminopyridines and pyrazolones has little effect on the course and efficiency of the dehydrogenative cross-coupling process. Based on the results of ^1^H NMR and ^13^C{^1^H} NMR spectroscopic studies and X-ray single-crystallographic analysis **6b** and **6k** ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}), reactions of **3a--f** with **4a--c** each produce only (*Z*)-isomers of the 1,2-diamino-6-(pyrazol-4-ylidene)-4-arylpyridine-3-carbonitriles **6a-s** in high yields.

###### Acetic Acid-Promoted Dehydrogenative Cross-Coupling Reactions of 1-Amino-2-imino-pyridines **3a--f** with Pyrazolones **4a--d**[a](#t2fn1){ref-type="table-fn"}

![](ao-2019-01650b_0007){#GRAPHIC-d7e1003-autogenerated}

![](ao-2019-01650b_0008){#gr7}

Reaction conditions: 1-amino-2-imino-pyridine **3a--f** (3 mmol), pyrazolone **4a--d** (3 mmol), in ethanol (10 mL), containing acetic acid (6 equiv), under O~2~ (1 atm) at 130 °C for 24 h.

A plausible mechanism for the new (pyrazol-4-ylidene)pyridine-forming cross-coupling reaction is displayed in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}. In the pathway, HOAc-promoted protonation activates the 1-amino-2-imino-pyridine **3** for C-addition of the enol form of the pyrazolone produced by HOAc-induced enolization. The adduct **A**, generated in this manner, then undergoes dehydrogenation through reaction with molecular oxygen to form the (pyrazol-4-ylidene)pyridine **6** product.

![Plausible Mechanism for Formation of (Pyrazol-4-ylidene)pyridines **6** in HOAc-Promoted Dehydrogenative Cross-Coupling Reactions of 1-Amino-2-imino-pyridines **3** with Pyrazolones **4**](ao-2019-01650b_0005){#sch3}

Finally, the utility of this CDC coupling on a laboratory preparative scale has been probed. We observed that a gram scale (10 mmol) reaction of **3a** with **4a** under the optimal conditions produces **6a** in 90% isolated yield ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Gram Scale Synthesis of **6a**](ao-2019-01650b_0006){#sch4}

Conclusions {#sec3}
===========

In summary, in the effort discussed above, we conducted an efficient metal catalyst-free aerobic dehydrogenative cross-coupling reaction between the 1-amino-2-imino-pyridines and 1-aryl-5-pyrazolones, which generates (pyrazol-4-ylidene)pyridines. The process has a high functional group tolerance and atom economy, and it employs simple, environmentally compatible reaction and purification procedures. As such, the protocol should find future applications to the synthesis of these N*-*heterocycles of pharmaceutical and agricultural interest.

Experimental Section {#sec4}
====================

General {#sec4.1}
-------

Melting points were recorded on a Griffin melting point apparatus and are uncorrected. IR spectra were recorded using KBr disks using a Jasco FT-IR-6300 spectrophotometer. ^1^H NMR (400 MHz) or (600 MHz) and ^13^C{^1^H} NMR (100 MHz) or (150 MHz) spectra were recorded at 25 °C using DMSO-*d*~6~ as a solvent with TMS as the internal standard on a Bruker DPX 400 or 600 super-conducting NMR spectrometer. Chemical shifts (δ) are reported in ppm. Low-resolution electron impact mass spectra \[MS (EI)\] and high-resolution electron impact mass spectra \[HRMS (EI)\] were performed using a high-resolution GC--MS (DFS) thermo spectrometer at 70.1 eV and a magnetic sector mass analyzer. Following that, the courses of reactions and checking homogeneity of products were performed using thin-layer chromatography. The X-ray crystallographic data were collected by using a Rigaku R-AXIS RAPID diffractometer and Bruker X8 Prospector at room temperature by using Cu Kα radiation. The structures were solved by using direct methods and expanded using Fourier techniques. The nonhydrogen atoms were refined anisotropically. The structures were solved and refined using the Bruker SHELXTL Software Package (Structure solution program- SHELXS-97 and Refinement program- SHELXL-97).^[@ref91]^ Data were corrected for the absorption effects using the multiscan method (SADABS). The arylethylidenemalononitriles **1a--f**([@ref92]) and enaminonitriles **2a--f**([@ref93]) were prepared according to literature procedures.

General Procedure for the Preparation of 1-Amino-2-imino-4-aryl-1,2-dihydropyridine-3-carbonitrile **3a--f**([@cit44b]) {#sec4.2}
-----------------------------------------------------------------------------------------------------------------------

A mixture of the enaminonitrile **2** (20 mmol) and hydrazine hydrate (1.5 mL, 30 mmol) in 60 mL of ethanol was stirred at reflux for 1 h. The mixture was concentrated in vacuo giving a solid that was crystallized from the appropriate solvent to give **3** as the pure product.

1-Amino-4-(4-chlorophenyl)-2-imino-1,2-dihydropyridine-3-carbonitrile (**3a**) {#sec4.3}
------------------------------------------------------------------------------

It is obtained as bright yellow crystals; yield: 4.35 g (89%); mp 234--235 °C, IR (KBr) *ν*/cm^--1^: 3314, 3267 (NH~2~), 3178 (NH), 2210 (CN); ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 5.89 (d, *J* = 6.8 Hz, 1H), 6.16 (s, 2H), 6.61 (brs, 1H), 7.61--7.63 (m, 4H), 7.81 (d, *J* = 6.8 Hz, 1H); ^13^C{^1^H} NMR (100 MHz, DMSO-*d*~6~): δ 101.3, 116.8, 128.8, 129.7, 134.8, 135.0, 143.1153.9, 154.3; MS (EI) *m*/*z*: (%) 246 (M^+^ + 2, 34.29), 245 (M^+^ + 1, 17.94), 244 (M^+^, 100); HRMS (EI) *m*/*z*: calcd for C~12~H~9~N~4~Cl(M^+^) 244.0510; found, 244.0510.

1-Amino-4-(4-bromophenyl)-2-imino-1,2-dihydropyridine-3-carbonitrile (**3b**) {#sec4.4}
-----------------------------------------------------------------------------

It is obtained as yellow crystals; yield: 5.3 g (92%); mp 239--240 °C, IR (KBr) *ν*/cm^--1^: 3311, 3263 (NH~2~), 3176 (NH), 2208 (CN); ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 5.90 (d, *J* = 6.8 Hz, 1H), 6.17 (s, 2H), 6.73 (brs, 1H), 7.54 (d, *J* = 8.4 Hz, 2H), 7.74 (d, *J* = 8.4 Hz, 2H), 7.82 (d, *J* = 6.8 Hz, 1H); ^13^C{^1^H} NMR (100 MHz, DMSO-*d*~6~): δ 102.2, 116.6, 123.7, 130.0, 131.8, 135.3, 143.4, 143.4, 154.2, 154.3; MS (EI) *m*/*z*: (%) 290 (M^+^ + 2, 97.06), 289 (M^+^ + 1, 18.49), 288 (M^+^, 100); HRMS (EI) *m*/*z*: calcd for C~12~H~9~N~4~Br(M^+^) 288.0005; found, 288.0005.

1-Amino-4-(4-fluorophenyl)-2-imino-1,2-dihydropyridine-3-carbonitrile (**3c**) {#sec4.5}
------------------------------------------------------------------------------

It is obtained as yellow crystals; yield: 4.35 g (89%); mp 200--201 °C, IR (KBr) *ν*/cm^--1^: 3312, 3258 (NH~2~), 3175 (NH), 2209 (CN); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 5.89 (d, *J* = 7.2 Hz, 1H), 6.11 (s, 2H), 6.63 (brs, 1H), 7.33--7.36 (m, 2H), 7.63--7.65 (m, 2H), 7.78 (d, *J* = 7.2 Hz, 1H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 101.3, (115.47, 115.62) (d, ^2^*J*~CF~ = 22.5 Hz), 116.7, (129.97, 130.03) (d, ^3^*J*~CF~ = 9.0 Hz), 132.47, 132.49, 142.7, 153.8, 154.3, (162.01, 163.65) (d, ^1^*J*~CF~ = 246 Hz); MS (EI) *m*/*z*: (%) 229 (M^+^ + 1, 28.75), 228 (M^+^, 100); HRMS (EI) *m*/*z*: calcd for C~12~H~9~N~4~F(M^+^) 228.0806; found, 228.0806.

1-Amino-2-imino-4-(4-nitrophenyl)-1,2-dihydropyridine-3-carbonitrile (**3d**) {#sec4.6}
-----------------------------------------------------------------------------

It is obtained as yellow crystals; yield: 4.4 g (87%); mp 207--208 °C, IR (KBr) *ν*/cm^--1^: 3312, 3255 (NH~2~), 3161 (NH), 2206 (CN); ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 5.94 (d, *J* = 7.2 Hz, 1H), 6.23 (brs, 2H), 6.74 (brs, 1H), 7.85--7.87 (m, 3H), 8.36 (d, *J* = 7.6 Hz, 2H); ^13^C{^1^H} NMR (100 MHz, DMSO-*d*~6~): δ 97.7, 101.3, 116.5, 123.9, 129.5, 142.5, 143.6, 148.2, 153.1, 154.0; MS (EI) *m*/*z*: (%) 256 (M^+^ + 1, 17.92), 255 (M^+^, 100); HRMS (EI) *m*/*z*: calcd for C~12~H~9~N~5~O~2~(M^+^) 255.0751; found, 255.0750.

1-Amino-2-imino-4-phenyl-1,2-dihydropyridine-3-carbonitrile (**3e**) {#sec4.7}
--------------------------------------------------------------------

It is obtained as yellow crystals; yield: 3.7 g (89%); mp 165--166 °C, IR (KBr) *ν*/cm^--1^: 3318, 3226 (NH~2~), 3137 (NH), 2211 (CN); ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 5.90 (d, *J* = 7.2 Hz, 1H), 6.16 (s, 2H), 6.53 (brs, 1H), 7.52--7.59 (m, 5H), 7.81 (d, *J* = 7.2 Hz, 1H); ^13^C{^1^H} NMR (100 MHz, DMSO-*d*~6~): δ 97.2, 101.6, 117.1, 127.8, 128.8, 130.1, 136.3, 143.1, 154.6, 155.1; MS (EI) *m*/*z* (%) 211 (M^+^ + 1, 18.25), 210 (M^+^, 100); HRMS (EI) *m*/*z* calcd for C~12~H~10~N~4~ (M^+^) 210.0899; found, 210.0899.

1-Amino-2-imino-4-*p*-tolyl-1,2-dihydropyridine-3-carbonitrile (**3f**) {#sec4.8}
-----------------------------------------------------------------------

It is obtained as yellow crystals; yield: 4.3 g (90%); mp 223--224 °C, IR (KBr) *ν*/cm^--1^: 3315, 3262 (NH~2~), 3171 (NH), 2207 (CN); ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 2.38 (s, 3H), 5.88 (d, *J* = 7.2 Hz, 1H), 6.13 (s, 2H), 6.58 (brs, 1H), 7.34 (d, *J* = 8.0 Hz, 2H), 7.48 (d, *J* = 8.0 Hz, 2H), 7.79 (d, *J* = 7.2 Hz, 1H); ^13^C{^1^H} NMR (100 MHz, DMSO-*d*~6~): δ 20.9, 101.6, 117.2, 127.7, 129.3, 133.3, 140.0, 142.6, 143.0, 154.6, 155.0; MS (EI) *m*/*z* (%) 225 (M^+^ + 1, 13.19), 224 (M^+^, 72.89); HRMS (EI) *m*/*z* calcd for C~13~H~12~N~4~ (M^+^) 224.1056; found, 224.1055.

7-(4-Chlorophenyl)\[1,2,4\]triazolo\[1,5-*a*\]pyridine-8-carbonitrile (**5a**) {#sec4.9}
------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (3:1) as yellow crystals; yield: 0.55 g (72%), mp above 300 °C; IR (KBr) *ν*/cm^--1^: 2226 (CN); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 7.48 (d, *J* = 7.2 Hz, 1H), 7.70 (d, *J* = 8.4 Hz, 2H), 7.80 (d, *J* = 8.4 Hz, 2H), 8.75 (s, 1H), 9.35 (d, *J* = 7.2 Hz, 1H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 97.8, 114.4, 115.4, 129.1, 130.8, 133.2, 134.2, 135.3, 148.3, 149.6, 155.5; MS (EI) *m*/*z* (%) 256 (M^+^ + 2, 33.19), 255 (M^+^ + 1, 16.29), 254 (M^+^, 100). HRMS (EI) *m/z* calcd for C~13~H~7~ClN~4~ (M^+^) 254.1147; found, 254.1147.

7-(4-Chlorophenyl)-2-methyl\[1,2,4\]triazolo\[1,5-*a*\]pyridine-8-carbonitrile (**5b**) {#sec4.10}
---------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (3:1) as buff crystals; yield: 0.6 g (74%), mp 225--226 °C; IR (KBr) *ν*/cm^--1^: 2223 (CN); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.54 (s, 3H), 7.36 (d, *J* = 6.8 Hz, 1H), 7.67 (d, *J* = 8.4 Hz, 2H), 7.76 (d, *J* = 8.4 Hz, 2H), 9.20 (d, *J* = 6.8 Hz, 1H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 14.1, 96.6, 114.5, 128.7, 129.1, 130.7, 132.6, 134.3, 135.2, 147.8, 150.2, 165.1; MS (EI): *m*/*z* (%) 270 (M^+^ + 2, 29.65), 269 (M^+^ + 1, 14.89), 268 (M^+^, 100). HRMS (EI): *m/z* calcd for C~14~H~10~ClN~4~ (M^+^) 268.1147; found, 268.1147.

General Procedure for the Preparation of (Pyrazol-4-ylidene)pyridines Derivatives **6a--s** {#sec4.11}
-------------------------------------------------------------------------------------------

A mixture of the 1-amino-2-imino-pyridine **3** (3 mmol) and pyrazolone derivative **4** (3 mmol) in ethanol (10 mL) containing acetic acid (6 equiv) under O~2~ (1 atm) was stirred at 130 °C for 24 h. The mixture was then cooled to room temperature. The formed solid was collected by filtration and recrystallized from the appropriate solvent (see below) to give the (pyrazol-4-ylidene)pyridine **6**.

(*Z*)-1,2-Diamino-4-(4-chlorophenyl)-6-(3-methyl-5-oxo-1-phenyl-1*H*-pyrazol-4(5*H*)-ylidene)-1,6-dihydropyridine-3-carbonitrile (**6a**) {#sec4.12}
-----------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:2) as deep orange crystals; yield: 1.15 g (92%), mp above 300 °C; IR (KBr) *ν*/cm^--1^: 3338, 3298, 3262, 3237 (2NH~2~), 2213 (CN), 1659 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.28 (s, 3H), 6.72 (s, 1H), 7.08 (t, *J* = 7.8 Hz, 1H), 7.34--7.36 (m, 4H), 7.66 (d, *J* = 8.4 Hz, 2H), 7.71 (d, *J* = 8.4 Hz, 2H), 8.03 (d, *J* = 7.8 Hz, 2H), 8.64 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 82.7, 96.2, 110.5, 115.3, 118.3, 123.2, 128.4, 128.9, 130.2, 134.5, 135,3, 140.0, 146.6, 151.8, 153.8, 157.3, 162.4; MS (EI): *m*/*z* (%) 417 (M^+^ + 1, 34.78), 416 (M^+^, 100). HRMS (EI): *m/z* calcd for C~22~H~17~ClN~6~O (M^+^) 416.1147; found, 416.1147.

(*Z*)-1,2-Diamino-4-(4-bromophenyl)-6-(3-methyl-5-oxo-1-phenyl-1*H*-pyrazol-4(5*H*)-ylidene)-1,6-dihydropyridine-3-carbonitrile (**6b**) {#sec4.13}
----------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:1) or from aqueous DMSO for the X-ray single crystal as orange crystals; yield: 1.3 g (94%), mp 296--297 °C; IR (KBr) *ν*/cm^--1^: 3371, 3316, 3244, 3102 (2NH~2~), 2216 (CN), 1664 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.29 (s, 3H), 6.73 (s, 1H), 7.09 (t, *J* = 7.8 Hz, 1H), 7.35--7.37 (m, 4H), 7.64 (d, *J* = 7.8 Hz, 2H), 7.80 (d, *J* = 7.8 Hz, 2H), 8.04 (d, *J* = 7.8 Hz, 2H), 8.65 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 82.6, 96.2, 110.4, 115.3, 118.3, 123.2, 124.1, 128.4, 130.4, 131.9, 134.9, 140.0, 146.6, 151.8, 153.8, 157.3, 162.4; MS (EI): *m*/*z* (%) 462 (M^+^ + 2, 100), 461 (M^+^ + 1, 27.15), 460 (M^+^, 97.98). HRMS (EI): *m/z* calcd for C~22~H~17~BrN~6~O (M^+^) 460.0642; found, 460.0643. Crystal Data, moiety formula: 2(C~22~H~17~BrN~6~O), H~2~O, *M* = 940.65, monoclinic, *a* = 17.61(2) Å, *b* = 7.593(6) Å, *c* = 15.88(2) Å, *V* = 2007(3) Å^3^, α = γ = 90°, β = 109.057(9)°, space group: *P*2/*c* (\#13), *Z* = 2, *D*~calc~ = 1.556 g·cm^--3^, no. of reflection measured 3482, 2θ~max~ = 50.1°, R1 = 0.0694 (CCDC 1889196).^[@ref95]^

(*Z*)-1,2-Diamino-4-(4-fluorophenyl)-6-(3-methyl-5-oxo-1-phenyl-1*H*-pyrazol-4(5*H*)-ylidene)-1,6-dihydropyridine-3-carbonitrile (**6c**) {#sec4.14}
-----------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:1) as deep orange crystals; yield: 1.05 g (88%), mp above 300 °C; IR (KBr) *ν*/cm^--1^: 3325, 3284, 3231, 3145 (2NH~2~), 2215 (CN), 1661 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.28 (s, 3H), 6.72 (s, 1H), 7.08 (t, *J* = 7.2 Hz, 1H), 7.34--7.37 (m, 4H), 7.42 (t, *J* = 7.2 Hz, 2H), 7.75--7.77 (m, 2H), 8.04 (d, *J* = 7.2 Hz, 2H), 8.63 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 82.8, 96.1, 110.6, 115.4, (115.87, 116.01) (d, ^2^*J*~CF~ = 21.0 Hz), 118.3, 123.2, 128.5, (130.80, 130.86) (d, ^3^*J*~CF~ = 9.0 Hz), 132.1, 140.0, 146.6, 152.0, 153.7, 157.3, 162.4, (162.48, 164.12) (d, ^1^*J*~CF~ = 246 Hz); MS (EI): *m*/*z* (%) 401 (M^+^ + 1, 3.97), 400 (M^+^, 13.05), 385 (M^+^ -- 15, 100). HRMS (EI): *m/z* calcd for C~22~H~17~FN~6~O (M^+^) 400.1442; found, 400.1442.

(*Z*)-1,2-Diamino-6-(3-methyl-5-oxo-1-phenyl-1*H*-pyrazol-4(5*H*)-ylidene)-4-(4-nitrophenyl)-1,6-dihydropyridine-3-carbonitrile (**6d**) {#sec4.15}
----------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:1) as orange crystals; yield: 1.14 g (89%), mp above 300 °C; IR (KBr) *ν*/cm^--1^: 3449, 3370, 3278, 3215 (2NH~2~), 2212 (CN), 1638 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.29 (s, 3H), 6.78 (s, 1H), 7.08 (t, *J* = 7.8 Hz, 1H), 7.35--7.37 (m, 4H), 7.96 (d, *J* = 9.0 Hz, 2H), 8.03 (d, *J* = 7.8 Hz, 2H), 8.40 (d, *J* = 9.0 Hz, 2H), 8.72 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 82.6, 96.5, 110.6, 115.1, 118.3, 123.2, 123.9, 128.5, 130.0, 139.9, 142.0, 146.7, 148.4, 150.8, 153.9, 157.2, 162.4; MS (EI): *m*/*z* (%) 428 (M^+^ + 1, 27.85), 427 (M^+^, 100). HRMS (EI): *m/z* calcd for C~22~H~17~N~7~O~3~ (M^+^) 427.1387; found, 427.1387.

(*Z*)-1,2-Diamino-6-(3-methyl-5-oxo-1-phenyl-1*H*-pyrazol-4(5*H*)-ylidene)-4-phenyl-1,6-dihydropyridine-3-carbonitrile (**6e**) {#sec4.16}
-------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (3:1) as orange crystals; yield: 0.90 g (79%), mp 252--253 °C; IR (KBr) *ν*/cm^--1^: 3354, 3291, 3249, 3198 (2NH~2~), 2214 (CN), 1661 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.29 (s, 3H), 6.72 (s, 1H), 7.07 (t, *J* = 7.8 Hz, 1H), 7.34--7.36 (m, 4H), 7.51--7.68 (m, 5H), 8.05 (d, *J* = 7.8 Hz, 2H), 8.59 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 82.8, 96.0, 110.5, 115.4, 118.3, 123.1, 128.2, 128.9, 130.4, 132.9, 135.7, 140.0, 146.6, 153.1, 153.7, 157.3, 162.4; MS (EI): *m*/*z* (%) 383 (M^+^ + 1, 41.89), 382 (M^+^, 94.08), 367 (M^+^ -- 15, 100). HRMS (EI): *m/z* calcd for C~22~H~18~N~6~O (M^+^) 382.1537; found, 382.1536.

(*Z*)-1,2-Diamino-4-(4-chlorophenyl)-6-(3-methyl-5-oxo-1-*p*-tolyl-1*H*-pyrazol-4(5*H*)-ylidene)-1,6-dihydropyridine-3-carbonitrile (**6f**) {#sec4.17}
--------------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:2) as orange crystals; yield: 1.08 g (83%), mp 294--295 °C; IR (KBr) *ν*/cm^--1^: 3417, 3365, 3308, 3242 (2NH~2~), 2217 (CN), 1654 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.26 (s, 3H), 2.28 (s, 3H), 6.70 (s, 1H), 7.15 (d, *J* = 8.4 Hz, 2H), 7.38 (s, 2H), 7.65 (d, *J* = 9.0 Hz, 2H), 7.70 (d, *J* = 9.0 Hz, 2H), 7.89 (d, *J* = 8.4 Hz, 2H), 8.64 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 20.5, 82.5, 96.2, 110.4, 115.3, 118.3, 128.8, 128.9, 130.2, 132.0, 134.5, 135.3, 137.7, 146.3, 151.6, 153.7, 157.3, 162.2; MS (EI): *m*/*z* (%) 432 (M^+^ + 2, 32.18), 431 (M^+^ + 1, 28.89), 430 (M^+^, 100). HRMS (EI): *m/z* calcd for C~23~H~19~ClN~6~O (M^+^) 430.1303; found, 430.1302.

(*Z*)-1,2-Diamino-4-(4-bromophenyl)-6-(3-methyl-5-oxo-1-*p*-tolyl-1*H*-pyrazol-4(5*H*)-ylidene)-1,6-dihydropyridine-3-carbonitrile (**6g**) {#sec4.18}
-------------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:2) as orange crystals; yield: 1.22 g (86%), mp 299--300 °C; IR (KBr) *ν*/cm^--1^: 3370, 3295, 3210, 3104 (2NH~2~), 2216 (CN), 1661 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.26 (s, 3H), 2.28 (s, 3H), 6.70 (s, 1H), 7.15 (d, *J* = 8.4 Hz, 2H), 7.37 (s, 2H), 7.62 (d, *J* = 8.4 Hz, 2H), 7.78 (d, *J* = 8.4 Hz, 2H), 7.88 (d, *J* = 8.4 Hz, 2H), 8.62 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 20.5, 82.5, 96.3, 110.4, 115.4, 118.3, 124.1, 128.9, 130.4, 131.9, 132.1, 134.9, 137.7, 146.3, 151.7, 153.8, 157.3, 162.2; MS (EI): *m*/*z* (%) 476 (M^+^ + 2, 42.39), 475 (M^+^ + 1, 12.75), 474 (M^+^, 43.18), 461 (100). HRMS (EI): *m/z* calcd for C~23~H~19~BrN~6~O (M^+^) 474.0798; found, 474.0798.

(*Z*)-1,2-Diamino-4-(fluorophenyl)-6-(3-methyl-5-oxo-1-*p*-tolyl-1*H*-pyrazol-4(5*H*)-ylidene)-1,6-dihydropyridine-3-carbonitrile (**6h**) {#sec4.19}
------------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:1) as orange crystals; yield: 0.98 g (79%), mp 280--281 °C; IR (KBr) *ν*/cm^--1^: 3365, 3280, 3228, 3115 (2NH~2~), 2214 (CN), 1658 cm^--1^ (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.27 (s, 3H), 2.29 (s, 3H), 6.71 (s, 1H), 7.15 (d, *J* = 7.8 Hz, 2H), 7.26 (d, *J* = 8.4 Hz, 2H), 7.37 (s, 2H), 7.64 (d, *J* = 8.4 Hz, 2H), 7.89 (d, *J* = 7.8 Hz, 2H), 8.61 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 20.5, 82.5, 96.2, 110.5, 115.4, (115.93, 116.09) (d, ^2^*J*~CF~ = 24.0 Hz), 118.3, 123.9, 128.7, (130.56, 130.64) (d, ^3^*J*~CF~ = 12.0 Hz), 132.0, 139.0, 145.9, 151.9, 153.8, 157.3, 162.2, (162.55, 164.21) (d, ^1^*J*~CF~ = 249 Hz); MS (EI): *m*/*z* (%) 415 (M^+^ + 1, 16.88), 414 (M^+^, 60.97), 399 (M^+^ -- 15, 100). HRMS (EI): *m/z* calcd for C~23~H~19~FN~6~O (M^+^) 414.1599; found, 414.1598.

(*Z*)-1,2-Diamino-6-(3-methyl-5-oxo-1-*p*-tolyl-1H-pyrazol-4(5*H*)-ylidene)-4-(4-nitrophenyl)-1,6-dihydropyridine-3-carbonitrile (**6i**) {#sec4.20}
-----------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (2:1) as reddish brown crystals; yield: 0.97 g (74%), mp 272--273 °C; IR (KBr) *ν*/cm^--1^: 3422, 3358, 3287, 3206 (2NH~2~), 2216 (CN), 1657 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.27 (s, 3H), 2.28 (s, 3H), 6.77 (s, 1H), 7.16 (d, *J* = 8.4 Hz, 2H), 7.38 (s, 2H), 7.89 (d, *J* = 8.4 Hz, 2H), 7.95 (d, *J* = 8.4 Hz, 2H), 8.40 (d, *J* = 8.4 Hz, 2H), 8.70 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 20.4, 82.3, 96.5, 110.6, 115.1, 118.3, 123.9, 128.8, 129.9, 132.1, 137.6, 142.0, 146.3, 148.4, 150.6, 153.9, 157.2, 162.2; MS (EI): *m*/*z* (%) 442 (M^+^ + 1, 15.62), 441 (M^+^, 56.18), 426 (M^+^ -- 15, 100). HRMS (EI): *m/z* calcd for C~23~H~19~N~7~O~3~ (M^+^) 441.1544; found, 441.1545.

(*Z*)-1,2-Diamino-6-(3-methyl-5-oxo-1-*p*-tolyl-1*H*-pyrazol-4(5*H*)-ylidene)-4-phenyl-1,6-dihydropyridine-3-carbonitrile (**6j**) {#sec4.21}
----------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:1) as orange crystals; yield: 0.95 g (81%), mp 286--287 °C; IR (KBr) *ν*/cm^--1^: 3408, 3345, 3289, 3133 (2NH~2~), 2220 (CN), 1655 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.27 (s, 3H), 2.28 (s, 3H), 6.71 (s, 1H), 7.15 (d, *J* = 8.4 Hz, 2H), 7.38 (s, 2H), 7.58--7.59 (m, 3H), 7.68--7.69 (m, 2H), 7.90 (d, *J* = 8.4 Hz, 2H), 8.60 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 20.5, 82.6, 96.1, 110.5, 115.5, 118.3, 128.2, 128.8, 128.9, 130.4, 132.0, 135.7, 137.7, 146.2, 152.9, 153.7, 157.4, 162.2; MS (EI): *m*/*z* (%) 397 (M^+^ + 1, 14.08), 396 (M^+^, 51.14). HRMS (EI): *m/z* calcd for C~23~H~20~N~6~O (M^+^) 396.1693; found, 396.1694.

(*Z*)-1,2-Diamino-6-(3-methyl-5-oxo-1-*p*-tolyl-1*H*-pyrazol-4(5*H*)-ylidene)-4-*p*-tolyl-1,6-dihydropyridine-3-carbonitrile (**6k**) {#sec4.22}
-------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the MeOH/dioxane mixture (1:2) as orange crystals; yield: 0.92 g (75%), mp above 300 °C; IR (KBr) *ν*/cm^--1^: 3378, 3328, 3260, 3172 (2NH~2~), 2213 (CN), 1641 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.27 (s, 3H), 2.28 (s, 3H), 2.40 (s, 3H), 6.68 (s, 1H), 7.15 (d, *J* = 8.4 Hz, 2H), 7.37 (s, 2H), 7.39 (d, *J* = 8.4 Hz, 2H), 7.58 (d, *J* = 8.4 Hz, 2H), 7.90 (d, *J* = 8.4 Hz, 2H),8.56 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.7, 20.4, 20.9, 82.5, 96.0, 110.3, 115.6, 118.3, 128.2, 128.8, 129.5, 132.0, 132.9, 137.7, 140.4, 146.2, 153.0, 157.4, 162.2; MS (EI): *m*/*z* (%) 411 (M^+^ + 1, 9.05), 410 (M^+^, 31.22), 395 (M^+^ -- 15, 100). HRMS (EI): *m/z* calcd for C~24~H~22~N~6~O (M^+^) 410.1850; found, 410.1849. Crystal Data, moiety formula: C~24~H~22~N~6~O, M = 410.48, monoclinic, *a* = 24.0794(10) Å, *b* = 4.5338(2) Å, *c* = 19.1155(7) Å, *V* = 2085.15(15) Å^3^, α = γ = 90°, β = 92.320(3)°, space group: *P*21/*c*, *Z* = 4, *D*~calc~ = 1.308 g·cm^--3^, no. of reflection measured 3640, θ~max~ = 66.333°, R1 = 0.0565 (CCDC 1889196).^[@ref95]^

(*Z*)-1,2-Diamino-4-(4-chlorophenyl)-6-\[1-(4-chlorophenyl)-3-methyl-5-oxo-1*H*-pyrazol-4(5*H*)-ylidene\]-1,6-dihydropyridine-3-carbonitrile (**6l**) {#sec4.23}
-----------------------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:2) as deep orange crystals; yield: 1.20 g (89%), mp above 300 °C; IR (KBr) *ν*/cm^--1^: 3399, 3298, 3185, 3092 (2NH~2~), 2217 (CN), 1665 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.27 (s, 3H), 6.72 (s, 1H), 7.31 (s, 2H), 7.40 (d, *J* = 8.4 Hz, 2H), 7.60 (d, *J* = 7.8 Hz, 2H), 7.70 (d, *J* = 7.8 Hz, 2H), 8.08 (d, *J* = 8.4 Hz, 2H), 8.67 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.6, 83.1, 96.0, 110.6, 115.2, 119.5, 126.8, 128.4, 128.9, 130.2, 134.4, 135,4, 138.9, 147.2, 152.0, 153.7, 157.3, 162.4; MS (EI): *m*/*z* (%) 452 (M^+^ + 2, 61.23), 451 (M^+^ + 1, 24.98), 450 (M^+^, 100). HRMS (EI): *m/z* calcd for C~22~H~16~Cl~2~N~6~O (M^+^) 450.0757; found, 450.0757.

(*Z*)-1,2-Diamino-4-(4-bromophenyl)-6-\[1-(4-chlorophenyl)-3-methyl-5-oxo-1*H*-pyrazol-4(5*H*)-ylidene\]-1,6-dihydropyridine-3-carbonitrile (**6m**) {#sec4.24}
----------------------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:3) as deep orange crystals; yield: 1.38 g (93%), mp above 300 °C; IR (KBr) *ν*/cm^--1^: 3398, 3295, 3180, 3093 (2NH~2~), 2218 (CN), 1664 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.27 (s, 3H), 6.72 (s, 1H), 7.31 (s, 2H), 7.40 (d, *J* = 7.8 Hz, 2H), 7.63 (d, *J* = 7.8 Hz, 2H), 7.78 (d, *J* = 7.8 Hz, 2H), 8.09 (d, *J* = 7.8 Hz, 2H), 8.66 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.6, 83.0, 96.0, 110.5, 115.2, 119.4, 124.1, 126.8, 128.4, 130.4, 131.9, 134.8, 138.9, 147.2, 152.1, 153.7, 157.2, 162.4; MS (EI): *m*/*z* (%) 496 (M^+^ + 2, 100), 495 (M^+^ + 1, 21.13), 494 (M^+^, 75.04). HRMS (EI): *m/z* calcd for C~22~H~16~BrClN~6~O (M^+^) 494.0252; found, 494.0251.

(*Z*)-1,2-Diamino-6-\[1-(4-chlorophenyl)-3-methyl-5-oxo-1*H*-pyrazol-4(5*H*)-ylidene\]-4-(4-fluorophenyl)-1,6-dihydropyridine-3-carbonitrile (**6n**) {#sec4.25}
-----------------------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:2) as deep orange crystals; yield: 1.10 g (85%), mp above 300 °C; IR (KBr) *ν*/cm^--1^: 3394, 3293, 3190, 3111 (2NH~2~), 2220 (CN), 1658 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.28 (s, 3H), 6.72 (s, 1H), 7.31 (s, 2H), 7.40--7.44 (m, 4H), 7.74--7.77 (m, 2H), 8.09 (d, *J* = 8.4 Hz, 2H), 8.64 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.6, 83.3, 95.9, 110.6, 115.4, (115.87, 116.02) (d, ^2^*J*~CF~ = 22.5 Hz), 119.5, 126.8, 128.4, (130.82, 130.88) (d, ^3^*J*~CF~ = 9.0 Hz), 132.1, 138.9, 147.2, 152.2, 153.6, 157.3, 162.4, (162.50, 164.14) (d, ^1^*J*~CF~ = 246 Hz); MS (EI): *m*/*z* (%) 435 (M^+^ + 1, 5.83), 434 (M^+^, 20.78), 419 (M^+^ -- 15, 100). HRMS (EI): *m/z* calcd for C~22~H~16~ClFN~6~O (M^+^) 434.1053; found, 434.1053.

(*Z*)-1,2-Diamino-6-\[1-(4-chlorophenyl)-3-methyl-5-oxo-1*H*-pyrazol-4(5*H*)-ylidene\]-4-(4-nitrophenyl)-1,6-dihydropyridine-3-carbonitrile (**6o**) {#sec4.26}
----------------------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:2) as reddish orange crystals; yield: 1.15 g (83%), mp 298--299 °C; IR (KBr) *ν*/cm^--1^: 3457, 3327, 3218, 3137 (2NH~2~), 2214 (CN), 1659 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.28 (s, 3H), 6.78 (s, 1H), 7.32 (s, 2H), 7.40 (d, *J* = 8.4 Hz, 2H), 7.95 (d, *J* = 8.4 Hz, 2H), 8.08 (d, *J* = 8.4 Hz, 2H), 8.40 (d, *J* = 8.4 Hz, 2H), 8.74 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15, 83.0, 96.3, 110.7, 115.0, 119.5, 123.9, 126.9, 128.4, 130.0, 138.8, 141.9, 147.2, 148.4, 151.0, 153.8, 157.2, 162.4; MS (EI): *m*/*z* (%) 462 (M^+^ + 1, 8.01), 461 (M^+^, 23.85), 446 (M^+^ -- 15, 100). HRMS (EI): *m*/*z* calcd for C~22~H~16~ClN~7~O~3~ (M^+^) 461.0998; found, 461.0997.

(*Z*)-1,2-Diamino-6-\[1-(4-chlorophenyl)-3-methyl-5-oxo-1*H*-pyrazol-4(5*H*)-ylidene\]-4-phenyl-1,6-dihydropyridine-3-carbonitrile (**6p**) {#sec4.27}
-------------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:1) as bright orange crystals; yield: 1.0 g (81%), mp above 300 °C; IR (KBr) *ν*/cm^--1^: 3410, 3349, 3290, 3154 (2NH~2~), 2208 (CN), 1656 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 2.28 (s, 3H), 6.72 (s, 1H), 7.31 (s, 2H), 7.41 (d, *J* = 9.0 Hz, 2H), 7.58--7.59 (m, 3H), 7.68--7.69 (m, 2H), 8.10 (d, *J* = 9.0 Hz, 2H), 8.61 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 15.6, 83.2, 95.9, 110.6, 115.3, 119.5, 126.8, 128.3, 128.4, 128.9, 130.5, 135.6, 138.9, 147.2, 153.3, 153.6, 157.3, 162.4; MS (EI): *m*/*z* (%) 417 (M^+^ + 1, 4.75), 416 (M^+^, 14.28), 401 (M^+^ -- 15, 100). HRMS (EI): *m/z* calcd for C~22~H~17~ClN~6~O (M^+^) 416.1147; found, 416.1148.

(*Z*)-1,2-Diamino-4-(4-chlorophenyl)-6-(5-oxo-1,3-diphenyl-1*H*-pyrazol-4(5*H*)-ylidene)-1,6-dihydropyridine-3-carbonitrile (**6q**) {#sec4.28}
------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:2) as red crystals; yield: 1.05 g (75%), mp 294--295 °C; IR (KBr) *ν*/cm^--1^: 3415, 3313, 3275, 3112 (2NH~2~), 2212 (CN), 1637 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 5.93 (s, 1H), 7.14 (t, *J* = 7.2 Hz, 1H), 7.21 (d, *J* = 8.4 Hz, 2H), 7.39--7.44 (m, 5H), 7.49--7.50 (m, 4H), 7.59 (d, *J* = 7.2 Hz, 2H), 8.10 (d, *J* = 8.4 Hz, 2H), 8.71 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 83.0, 94.2, 112.6, 115.1, 118.7, 123.7, 128.2, 128.4, 128.5, 128.8, 129.5, 133.9, 134.2, 135.3, 139.9, 149.7, 150.7, 154.2, 157.2, 162.5; MS (EI): *m*/*z* (%) 480 (M^+^ + 2, 35.29), 479 (M^+^ + 1, 31.25), 478 (M^+^, 100). HRMS (EI): *m/z* calcd for C~27~H~19~ClN~6~O (M^+^) 478.1303; found, 478.1303.

(*Z*)-1,2-Diamino-4-(4-bromophenyl)-6-(5-oxo-1,3-diphenyl-1*H*-pyrazol-4(5*H*)-ylidene)-1,6-dihydropyridine-3-carbonitrile (**6r**) {#sec4.29}
-----------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:3) as reddish brown crystals; yield: 1.20 g (77%), mp 274--275 °C; IR (KBr) *ν*/cm^--1^: 3439, 3325, 3264, 3110 (2NH~2~), 2213 (CN), 1642 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 5.92 (s, 1H), 7.13--7.15 (m, 3H), 7.39--7.45 (m, 5H), 7.49 (s, 2H), 7.58 (d, *J* = 7.8 Hz, 2H), 7.63 (d, *J* = 8.4 Hz, 2H), 8.10 (d, *J* = 7.8 Hz, 2H), 8.71 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 82.9, 94.2, 112.5, 115.1, 118.7, 123.7, 124.0, 128.2, 128.4, 128.5, 129.7, 131.7, 133.9, 134.6, 139.9, 149.8, 150.7, 154.2, 157.2, 162.5; MS (EI): *m*/*z* (%) 524 (M^+^ + 2, 53.68), 523 (M^+^ + 1, 19.25), 522 (M^+^, 51.17), 509 (100). HRMS (EI): *m/z* calcd for C~27~H~19~BrN~6~O (M^+^) 522.0798; found, 522.0797.

(*Z*)-1,2-Diamino-4-(4-fluorophenyl)-6-(5-oxo-1,3-diphenyl-1*H*-pyrazol-4(5*H*)-ylidene)-1,6-dihydropyridine-3-carbonitrile (**6s**) {#sec4.30}
------------------------------------------------------------------------------------------------------------------------------------

It is recrystallized from the EtOH/dioxane mixture (1:1) as orange crystals; yield: 1.00 g (73%), mp 288--289 °C; IR (KBr) *ν*/cm^--1^: 3407, 3343, 3278, 3119 (2NH~2~), 2212 (CN), 1636 (CO); ^1^H NMR (600 MHz, DMSO-*d*~6~): δ 5.93 (s, 1H), 7.14 (t, *J* = 7.2 Hz, 1H), 7.23--7.28 (m, 4H), 7.39--7.46 (m, 5H), 7.49 (s, 2H), 7.59 (d, *J* = 7.2 Hz, 2H), 8.10 (d, *J* = 7.8 Hz, 2H), 8.68 (s, 2H); ^13^C{^1^H} NMR (150 MHz, DMSO-*d*~6~): δ 83.2, 94.2, 112.7, 115.3, (115.87, 116.01) (d, ^2^*J*~CF~ = 21.0 Hz), 118.8, 123.8, 128.3, 128.5, 128.6, (130.19, 130.25) (d, ^3^*J*~CF~ = 9.0 Hz), 131.9, 134.0, 140.0, 149.8, 151.0, 154.2, 157.3 162.6, (162.36, 164.01) (d, ^1^*J*~CF~ = 247.5 Hz); MS (EI): *m*/*z* (%) 463 (M^+^ + 1, 22.08), 462 (M^+^, 76.02), 447 (M^+^ -- 15, 100). HRMS (EI): *m/z* calcd for C~27~H~19~FN~6~O (M^+^) 462.1599; found, 462.1598.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b01650](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b01650).^1^H NMR, ^13^C{^1^H} NMR, MS, and HRMS spectra for the reported compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01650/suppl_file/ao9b01650_si_001.pdf))Crystal data for compound **6b** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01650/suppl_file/ao9b01650_si_002.cif))Crystal data for compound **6k** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01650/suppl_file/ao9b01650_si_003.cif))
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